Fidelity Investments
IMVT icon

Fidelity Investments’s Immunovant IMVT Stock Holding History

Fidelity Investments’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624M Sell
16,186,469
-761,419
-4% -$23.2M 0.03% 471
2026
Q1 		$421M Sell
16,947,888
-42,866
-0.3% -$1.11M 0.02% 575
2025
Q4 		$432M Buy
16,990,754
+2,261,199
+15% +$50.4M 0.02% 566
2025
Q3 		$237M Sell
14,729,555
-3,869,640
-21% -$62.6M 0.01% 772
2025
Q2 		$298M Buy
18,599,195
+1,358,160
+8% +$20.5M 0.02% 668
2025
Q1 		$295M Buy
17,241,035
+4,143,120
+32% +$86.7M 0.02% 660
2024
Q4 		$324M Buy
13,097,915
+560,344
+4% +$15.9M 0.02% 632
2024
Q3 		$357M Buy
12,537,571
+2,053,688
+20% +$60.6M 0.02% 599
2024
Q2 		$277M Buy
10,483,883
+2,827,938
+37% +$80.4M 0.02% 663
2024
Q1 		$247M Sell
7,655,945
-219,877
-3% -$8.02M 0.02% 714
2023
Q4 		$332M Buy
7,875,822
+127,276
+2% +$4.68M 0.03% 559
2023
Q3 		$297M Buy
7,748,546
+2,494,678
+47% +$56.4M 0.03% 561
2023
Q2 		$99.7M Buy
5,253,868
+1,106,899
+27% +$20.6M 0.01% 994
2023
Q1 		$64.3M Buy
4,146,969
+1,658,836
+67% +$28.8M 0.01% 1157
2022
Q4 		$44.2M Buy
2,488,133
+2,487,410
+344,040% +$31.3M ﹤0.01% 1302
2022
Q3 		$4K Buy
723
+23
+3% +$112 ﹤0.01% 4391
2022
Q2 		$3K Sell
700
-193
-22% -$834 ﹤0.01% 4460
2022
Q1 		$5K Buy
+893
New +$5.56K ﹤0.01% 4437
2020
Q4 		– Sell
-200,000
Closed -$7.04M – 4071
2020
Q3 		$7.04M Buy
+200,000
New +$6.02M ﹤0.01% 1949

Other funds holding IMVT

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments's IMVT Position: Q2 2026 in Review

Fidelity Investments reduced its Immunovant (IMVT) stake by 4.5% in Q2 2026, selling an estimated $23.2M and leaving 16,186,469 shares worth $624M. The position accounts for 0.03% of the portfolio, ranked #471.

Fidelity Investments first reported a position in IMVT in Q3 2020 and has held it in 19 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Fidelity Investments held 16,186,469 shares of Immunovant worth $624M as of Q2 2026.
  • Fidelity Investments sold 761,419 Immunovant shares in Q2 2026, an estimated $23.2M.
  • Immunovant made up 0.03% of Fidelity Investments's portfolio in Q2 2026, its #471 holding.
  • Fidelity Investments first reported a position in Immunovant in Q3 2020 and has held it in 19 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.